210 related articles for article (PubMed ID: 11751403)
1. Regulation of cyclin D1 and p16(INK4A) is critical for growth arrest during mammary involution.
Gadd M; Pisc C; Branda J; Ionescu-Tiba V; Nikolic Z; Yang C; Wang T; Shackleford GM; Cardiff RD; Schmidt EV
Cancer Res; 2001 Dec; 61(24):8811-9. PubMed ID: 11751403
[TBL] [Abstract][Full Text] [Related]
2. The role of Ink4a/Arf in ErbB2 mammary gland tumorigenesis.
D'Amico M; Wu K; Di Vizio D; Reutens AT; Stahl M; Fu M; Albanese C; Russell RG; Muller WJ; White M; Negassa A; Lee HW; DePinho RA; Pestell RG
Cancer Res; 2003 Jun; 63(12):3395-402. PubMed ID: 12810676
[TBL] [Abstract][Full Text] [Related]
3. The inhibitor of cyclin-dependent kinase 4a/alternative reading frame (INK4a/ARF) locus encoded proteins p16INK4a and p19ARF repress cyclin D1 transcription through distinct cis elements.
D'Amico M; Wu K; Fu M; Rao M; Albanese C; Russell RG; Lian H; Bregman D; White MA; Pestell RG
Cancer Res; 2004 Jun; 64(12):4122-30. PubMed ID: 15205322
[TBL] [Abstract][Full Text] [Related]
4. Cell cycle regulators in bladder cancer: relationship to schistosomiasis.
Eissa S; Ahmed MI; Said H; Zaghlool A; El-Ahmady O
IUBMB Life; 2004 Sep; 56(9):557-64. PubMed ID: 15590562
[TBL] [Abstract][Full Text] [Related]
5. Genetic and epigenetic alterations in lung tumors from bitransgenic Ki-rasG12C expressing mice.
Floyd HS; Jennings-Gee JE; Kock ND; Miller MS
Mol Carcinog; 2006 Jul; 45(7):506-17. PubMed ID: 16482519
[TBL] [Abstract][Full Text] [Related]
6. Mammary hyperplasia and carcinoma in MMTV-cyclin D1 transgenic mice.
Wang TC; Cardiff RD; Zukerberg L; Lees E; Arnold A; Schmidt EV
Nature; 1994 Jun; 369(6482):669-71. PubMed ID: 8208295
[TBL] [Abstract][Full Text] [Related]
7. The SV40 small t-antigen prevents mammary gland differentiation and induces breast cancer formation in transgenic mice; truncated large T-antigen molecules harboring the intact p53 and pRb binding region do not have this effect.
Goetz F; Tzeng YJ; Guhl E; Merker J; Graessmann M; Graessmann A
Oncogene; 2001 Apr; 20(18):2325-32. PubMed ID: 11402328
[TBL] [Abstract][Full Text] [Related]
8. Functional analysis of cyclin D2 and p27(Kip1) in cyclin D2 transgenic mouse mammary gland during development.
Kong G; Chua SS; Yijun Y; Kittrell F; Moraes RC; Medina D; Said TK
Oncogene; 2002 Oct; 21(47):7214-25. PubMed ID: 12370811
[TBL] [Abstract][Full Text] [Related]
9. The differential impact of p16(INK4a) or p19(ARF) deficiency on cell growth and tumorigenesis.
Sharpless NE; Ramsey MR; Balasubramanian P; Castrillon DH; DePinho RA
Oncogene; 2004 Jan; 23(2):379-85. PubMed ID: 14724566
[TBL] [Abstract][Full Text] [Related]
10. Tumors initiated by constitutive Cdk2 activation exhibit transforming growth factor beta resistance and acquire paracrine mitogenic stimulation during progression.
Corsino P; Davis B; Law M; Chytil A; Forrester E; Nørgaard P; Teoh N; Law B
Cancer Res; 2007 Apr; 67(7):3135-44. PubMed ID: 17409420
[TBL] [Abstract][Full Text] [Related]
11. Transgenic mice with mammary gland targeted expression of human cortactin do not develop (pre-malignant) breast tumors: studies in MMTV-cortactin and MMTV-cortactin/-cyclin D1 bitransgenic mice.
van Rossum AG; van Bragt MP; Schuuring-Scholtes E; van der Ploeg JC; van Krieken JH; Kluin PM; Schuuring E
BMC Cancer; 2006 Mar; 6():58. PubMed ID: 16536875
[TBL] [Abstract][Full Text] [Related]
12. Phenotype-rescue of cyclin-dependent kinase inhibitor p16/INK4A defects in a spontaneous canine cell model of breast cancer.
DeInnocentes P; Agarwal P; Bird RC
J Cell Biochem; 2009 Feb; 106(3):491-505. PubMed ID: 19130492
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of cell-cycle effectors of proliferation in bladder tumor epithelial cells by the p75NTR tumor suppressor.
Khwaja F; Djakiew D
Mol Carcinog; 2003 Mar; 36(3):153-60. PubMed ID: 12619038
[TBL] [Abstract][Full Text] [Related]
14. p16(INK4a) and p53 deficiency cooperate in tumorigenesis.
Sharpless NE; Alson S; Chan S; Silver DP; Castrillon DH; DePinho RA
Cancer Res; 2002 May; 62(10):2761-5. PubMed ID: 12019151
[TBL] [Abstract][Full Text] [Related]
15. Ovarian cancer cells that coexpress endogenous Rb and p16 are insensitive to overexpression of functional p16 protein.
Todd MC; Sclafani RA; Langan TA
Oncogene; 2000 Jan; 19(2):258-64. PubMed ID: 10645004
[TBL] [Abstract][Full Text] [Related]
16. Differential effects of p21(WAF1/CIP1) deficiency on MMTV-ras and MMTV-myc mammary tumor properties.
Bearss DJ; Lee RJ; Troyer DA; Pestell RG; Windle JJ
Cancer Res; 2002 Apr; 62(7):2077-84. PubMed ID: 11929828
[TBL] [Abstract][Full Text] [Related]
17. Overexpression and forced activation of stat5 in mammary gland of transgenic mice promotes cellular proliferation, enhances differentiation, and delays postlactational apoptosis.
Iavnilovitch E; Groner B; Barash I
Mol Cancer Res; 2002 Nov; 1(1):32-47. PubMed ID: 12496367
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of the low molecular weight cyclin E in transgenic mice induces metastatic mammary carcinomas through the disruption of the ARF-p53 pathway.
Akli S; Van Pelt CS; Bui T; Multani AS; Chang S; Johnson D; Tucker S; Keyomarsi K
Cancer Res; 2007 Aug; 67(15):7212-22. PubMed ID: 17671189
[TBL] [Abstract][Full Text] [Related]
19. Alternative mammary oncogenic pathways are induced by D-type cyclins; MMTV-cyclin D3 transgenic mice develop squamous cell carcinoma.
Pirkmaier A; Dow R; Ganiatsas S; Waring P; Warren K; Thompson A; Hendley J; Germain D
Oncogene; 2003 Jul; 22(28):4425-33. PubMed ID: 12853979
[TBL] [Abstract][Full Text] [Related]
20. Significance of beta-catenin and pRB pathway components in malignant ovarian germ cell tumours: INK4A promoter CpG island methylation is associated with cell proliferation.
Kawauchi S; Liu XP; Kawasaki K; Hirakawa T; Amada S; Furuya T; Oga A; Sasaki K
J Pathol; 2004 Nov; 204(3):268-76. PubMed ID: 15476271
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
